<sup>131</sup>I-MIBG与化疗联合治疗神经母细胞瘤的研究现状

朱瑞森

¹³¹I-MIBG与化疗联合治疗神经母细胞瘤的研究现状

朱瑞森

文章导航 > 国际放射医学核医学杂志 > 2005, 29 > 2: (50-52)

引用本文:

Citation:

¹³¹I-MIBG与化疗联合治疗神经母细胞瘤的研究现状

朱瑞森

200233 上海, 上海交通大学附属第六人民医院核医学科
中图分类号: R730.5

The study status of ¹³¹I-MIBG concomitant use with chemotherapy in the theray of neuroblastoma

ZHU Rui-sen

Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
CLC number: R730.5

摘要: 神经母细胞瘤是一种侵犯儿童、恶性程度高、对射线敏感的肿瘤,近年来主要用¹³¹I-间碘苄胍(¹³¹I-MIBG)与化疗进行联合治疗,获得了良好的效果。主要综述¹³¹I-MIBG与化疗、免疫治疗等联合治疗神经母细胞瘤的几个不同方法和路径,并讨论了联合治疗的机制。
- ¹³¹I-间碘苄胍 /
- 神经母细胞瘤 /
- 化疗
Abstract: Neuroblastoma,a childhood radiosensitive tumor, is very aggressive and maligment. The combination of ¹³¹I-metaiodobenzylguanidine(¹³¹I-MIBG) with chemotherapy has resently been employed in the treatment of advanced stage neuroblastoma with encouraging results. In this paper, we reviewed results that several different ways are being assessed of treating neuroblastoma by combining ¹³¹I-MIBG with chemotherapy and immumotherapy and discusioned about mechanism of combination therapy.
- ¹³¹I-metaiodobenzylguanidine /
- neuroblastoma /
- chemotherapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Hoefnagel CA. Radionuclide therapy revisited[J]. Eur J Nucl Med,1991, 18(6):408-431.
[2]	de Kraker J, Hoefnagel CA, Caron H, et al. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma[J]. Eur J Cancer, 1995, 31(4):600-602.
[3]	Mastrangelo R, Tornesello A, Losorella A, et al. Optimal use of the ¹³¹I-MIBG and cisplatin combination in advanced neuroblastoma[J].J Neuro Oncol, 1997, 31(1):153-158.
[4]	Feldman JM, Frankel M, Coleman RE. Platelet uptake thepheochromocytoma-scanning agent ¹³¹I-MIBG[J]. Metabolism, 1984, 33(5):397-399.
[5]	Meller S. Targeted radiotherapy for neuroblastoma[J]. Arch Dis Child,1997, 77(5):389-391.
[6]	Yanik GA, Levine JE, Matthay KK, et al. Pilot study of ¹³¹I-MIBG in combination with myelozblative chemotherapy and autologeus stem-cell support for treatment of neuroblastoma[J]. J Clin Oncol,2002, 20(8):2142-2149.
[7]	Mastrangelo S, Tornesello A, Diociaiuti L, et al. Treatment of advanced neuroblastoma:feasibility and therapeutic potential of a novel approach combining ¹³¹I-MIBG and multiple drug chemotheraoy[J]. BrJ Cancer, 2001, 84(4):460-464.
[8]	Klingebiel T, Bader P, Bares R, et al. Treatment of neuroblastoma stage 4 with ¹³¹I-MIBG, high dose chemotherapy and immuno therapy.A pilot study[J]. EurJ Cancer, 1998, 34(9):1398-1402.
[9]	Klingebiel T, Berthold F, Treuner J, et al. MIBG in the treatment of 47 patients with neuroblastoma:results of the German Neuroblastoma Trial[J]. Med Pediatr Oncol, 1991, 19(2):84-88.
[10]	Lashford LS, Lewis IJ, Fielding SL, et al. Phase I/Ⅱ study of iodine ¹³¹I-MIBG in Chemoresistant neuroblastoma:a United Kingdom Children's Cancer Study Group investigation[J]. J Clin Oncol, 1992,10(12):1889-1896.
[11]	Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to trestment[J]. J Clin Onco1,1993, 11(8):1466-1477.
[12]	Montalde PG, Raffaghello L, Guarnaccia F, et al. Increase of MIBG uptake and intracellular half-life during differentiation of human neuroblastoma cells[J]. Int J Cancer, 1996, 67(1):95-100.
[13]	Armour A, Cunningham SH, Gaze MN, et al. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro[J]. Br J Cancer, 1997, 75(4):470-476.
[14]	Klingebiel T, Handgretinger R, Herter M, et al. Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of ¹³¹I-MIBG.Prog[J]. Clin Biol Res, 1994, 385:309-317.
[15]	Voute PA, van de Kleij AJ, de kraker J, et al. Clinical experience with radiation euhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage Ⅳ[J]. Eur J Cancer, 1995, 31A(4):596-600.

[1]	傅宏亮 , 李佳宁 , 吴靖川 . ¹³¹I-MIBG治疗神经母细胞瘤的机制、原理和现状. 国际放射医学核医学杂志, 1999, 23(6): 247-250.
[2]	邵虹 . 神经母细胞瘤的影像学诊断. 国际放射医学核医学杂志, 2002, 26(4): 148-151.
[3]	刘阳 , 王会祥 , 周涛 . 神经母细胞瘤股骨远端干骺端骨转移全身骨显像分析. 国际放射医学核医学杂志, 2012, 36(1): 27-29. doi: 10.3760/cma.j.issn.1673-4114.2012.01.007
[4]	林福生 , 李凤英 , 张永令 . ¹³¹I-间碘苯甲基胍的神经母细胞瘤的闪烁扫描. 国际放射医学核医学杂志, 1985, 9(4): 276-276.
[5]	罗全勇 . MIBG及其衍生物的研究进展. 国际放射医学核医学杂志, 2002, 26(5): 216-219.
[6]	袁志斌 . PET显像在内分泌肿瘤中的应用. 国际放射医学核医学杂志, 2003, 27(5): 208-211.
[7]	叶大铸 , 马寄晓 . 奥曲肽及其类似物用于肿瘤诊断的进展. 国际放射医学核医学杂志, 2003, 27(3): 97-100.
[8]	周伟娜 , 王雪梅 . ¹²³I-间碘苄胍心脏神经显像的临床应用进展. 国际放射医学核医学杂志, 2011, 35(5): 257-261. doi: 10.3760/cma.j.issn.1673-4114.2011.05.001
[9]	王燕 , 唐谨 . 神经母细胞瘤的¹³¹I-MIBG显像. 国际放射医学核医学杂志, 1988, 12(1): 61-61.
[10]	沈钰如 , 马寄晓 . 放射性碘标记MIBG诊断儿童神经母细胞瘤的经验. 国际放射医学核医学杂志, 1991, 15(1): 49-50.